These data were presented in a poster session at the 2024 San Antonio Breast Cancer Symposium, held December 10-13 in San Antonio, TX.1 A copy of ...
News
- TerSera® Presents New Real-World Evidence on Treatment Outcomes of Goserelin ... - BioSpace
- Trial finds quality of life similar among patients with low-risk DCIS whether they received ...
Biomedical technology · Cardiology · Dentistry ... San Antonio Breast Cancer Symposium (SABCS) ... Medical Xpress is a web-based medical and health news ...
- Stirista Climbs to #4 on San Antonio Business Journal's 2024 Fast Track Awards
Biotechnology · Clinical Trials & Medical Discoveries · Dentistry · FDA ... San Antonio Business Journal's Fast Track Awards for 2024. This marks ...
- Relay Therapeutics Announces Updated Interim Data for RLY-2608 + Fulvestrant ... - BioSpace
SAN ANTONIO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc ... As the first of a new breed of biotech created at the intersection ...
- Significant Positive Results with Jaguar Health's Crofelemer for Cancer Therapy ... - Yahoo Finance
... San Antonio Breast Cancer Symposium (SABCS) about the recently ... Psyence Biomedical executes binding agreements with Optimi Health. Psyence ...